• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Delayed contrast MR may predict rheumatoid arthritis

Publication
Article
Diagnostic ImagingDiagnostic Imaging Vol 32 No 11
Volume 32
Issue 11

Delayed gadolinium enhancement during MR imaging of cartilage of the metacarpophalangeal joints in patients with rheumatoid arthritis is feasible at 3T and may help predict rheumatoid arthritis.

Delayed gadolinium enhancement during MR imaging of cartilage of the metacarpophalangeal joints in patients with rheumatoid arthritis is feasible at 3T and may help predict rheumatoid arthritis.

The procedure involves T1 mapping following intravenous contrast. Concentration of the contrast in cartilage is an indirect measure of glycosaminoglycan (GAG), a component of hyaline cartilage.

The absence of GAG during delayed-contrast MR may help assess cartilage degeneration in the morphologically normal-appearing second and third metacarpophalangeal joints in patients.

Phalangeal and metacarpal delayed-enhancement values in patients with rheumatoid arthritis were significantly lower than in control subjects, although joint thickness was comparable in both groups, according to the researchers. Cartilage damage is a common occurrence in rheumatoid arthritis patients, so imaging may help for diagnosis and treatment purposes (Radiol 2010;257:441-447).

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.